Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

August 30, 2019

Study Completion Date

September 30, 2019

Conditions
Corneal Endothelial Cell LossMydriasisCataract
Interventions
DRUG

Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).

Fydrane®. The active substances in Fydrane are: tropicamide 0.04 mg (anticholinergic), phenylephrine hydrochloride 0.62 mg (alpha sympathomimetic) and Lidocaine hydrochloride 2 mg (amide type local anaesthetics) for each 0.2 ml dose, equivalent to 0.2 mg of tropicamide, 3.1 mg of phenylephrine hydrochloride and 10 mg of lidocaine hydrochloride for 1 ml.

Trial Locations (1)

Unknown

Cairo University - Kasr Alainy hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04396301 - Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco | Biotech Hunter | Biotech Hunter